Gapping up
In reaction to strong earnings/guidance: MLNK +12%, VIMC +10%, (receives large order for a SVAC Solution Deployment in Baoding City, Hebei Province), BLIN +9.1%, PPHM +7.9%, SWHC +5.9%, PLAB +4.8%, URBN +3.5%, ( discloses thus far Q4 comparable retail segment net sales are mid single-digit positive), PDLI +1.5%, .
M&A news: SNI +12.6% (Variety report suggesting Discovery (DISCA) bid), VPHM +0.4% (Hart-Scott-Rodino waiting period expires for Shire's (SHPG) acquisition of ViroPharma ), .
Select solar names showing strength: SPWR +0.6% (Total, SunPower (SPWR) and Etrion secure financing with OPIC 70MWp Salvador Solar Project in Chile), TSL +0.6% (announces appointment of new CFO ), JASO +0.6% (announces Mr. Herman Zhao has been appointed the co's new chief financial officer ), .
Other news: CYTR +29.7% (reports highly statistically significant positive results from its Global Phase 2b Clinical Trial), ECTE +22.9% ( announces strategic partnership with Medical Technologies Innovation Asia), BGMD +15.7% (continued strength), NSTG +11.7% (announces adoption of the Prosigna Breast Cancer Assay by leading US clinical laboratories and cancer centers), NRF+10.7% (announces plan to spin-off Asset Management Business into a separate publicly traded company in a tax-free transaction), SPPI +10.2% (presents 'encouraging' FOLOTYN and MARQIBO clinical data), RNN +6.3% (Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin), BLDP +4.9% (to supply ElectraGen-ME fuel cell systems for a polot project in Idea Cellular's India telecom network), CGEN +4.6% (Compugen discloses discovery of five potential cancer targets for antibody drug conjugate therapy), MA +4% ( announces capital actions: 10-for-1 split, 83% increase in quarterly dividend, $3.5 bln share repurchase program), ARIA +3.6% (still checking), ALU +3.3% (BlackRock discloses new 10%+ passive positions in 13G; upgraded to Buy from Neutral at Citigroup), QCOR +3.2% (made open market purchases during Q4 of ~500,000 shares of Questcor common stock through Dec 10; the shares were purchased at an average price of $57.21 per share), SNE +2.2% (music licensing deal in India, according to reports), CBI +1.8% (awarded contract for LNG Liquefaction terminal), PLUG +1.6% (continued strength), MCP +1.2% ( announces new Board appointments: Constantine Karayannopoulos to be Board Chair), RGR +1% (following SWHC results), SSNI +1% (Waddell & Reed disclosed 12.3% passive stake in 13G filing out last night after the close), CAM +0.8% ( approves $750 mln increase in share repurchase authorization ), FNSR +0.6% (prices $225 mln of 0.50% of Convertible Senior Notes due 2033; offering was increased by $25 mln), CBOE +0.5% ( declares special cash dividend of $0.50 per share; increases stock repurchase authorization by $100 mln), GM +0.5% (to halt Australia production by 2017), COG +0.5% (Barron's profiles positive view on Cabot Oil & Gas), YNDX +0.2% (announces proposed offering of $600 mln Convertible Senior Notes and a 3 mln share Increase in the Company's Open Market Share Repurchase Plan).
Analyst comments: GRPN +2.6% (upgraded to Outperform from Market Perform at Wells Fargo), EOPN +2.1% (initiated with a Buy at Janney ), XONE +1.8% (initiated with a Buy at Jefferies), RVBD +1.3% (initiated with a Buy at Citigroup), QCOM +1% (assumed with a Buy from a Neutral at Citigroup), VJET +1% (initiated with a Hold at Jefferies; tgt $40), FE +1% (FirstEnergy upgraded to Neutral from Sell at Goldman), FFIV +0.7% (initiated with a Buy at Citigroup ), ARCW +0.7% (initiated with a Buy at Brean Capital), DDD +0.5% and SSYS +0.4% (initiated with a Buy at Jefferies), MMM +0.4% (upgraded to Buy from Neutral at Nomura)
M&A news: SNI +12.6% (Variety report suggesting Discovery (DISCA) bid), VPHM +0.4% (Hart-Scott-Rodino waiting period expires for Shire's (SHPG) acquisition of ViroPharma ), .
Select solar names showing strength: SPWR +0.6% (Total, SunPower (SPWR) and Etrion secure financing with OPIC 70MWp Salvador Solar Project in Chile), TSL +0.6% (announces appointment of new CFO ), JASO +0.6% (announces Mr. Herman Zhao has been appointed the co's new chief financial officer ), .
Other news: CYTR +29.7% (reports highly statistically significant positive results from its Global Phase 2b Clinical Trial), ECTE +22.9% ( announces strategic partnership with Medical Technologies Innovation Asia), BGMD +15.7% (continued strength), NSTG +11.7% (announces adoption of the Prosigna Breast Cancer Assay by leading US clinical laboratories and cancer centers), NRF+10.7% (announces plan to spin-off Asset Management Business into a separate publicly traded company in a tax-free transaction), SPPI +10.2% (presents 'encouraging' FOLOTYN and MARQIBO clinical data), RNN +6.3% (Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin), BLDP +4.9% (to supply ElectraGen-ME fuel cell systems for a polot project in Idea Cellular's India telecom network), CGEN +4.6% (Compugen discloses discovery of five potential cancer targets for antibody drug conjugate therapy), MA +4% ( announces capital actions: 10-for-1 split, 83% increase in quarterly dividend, $3.5 bln share repurchase program), ARIA +3.6% (still checking), ALU +3.3% (BlackRock discloses new 10%+ passive positions in 13G; upgraded to Buy from Neutral at Citigroup), QCOR +3.2% (made open market purchases during Q4 of ~500,000 shares of Questcor common stock through Dec 10; the shares were purchased at an average price of $57.21 per share), SNE +2.2% (music licensing deal in India, according to reports), CBI +1.8% (awarded contract for LNG Liquefaction terminal), PLUG +1.6% (continued strength), MCP +1.2% ( announces new Board appointments: Constantine Karayannopoulos to be Board Chair), RGR +1% (following SWHC results), SSNI +1% (Waddell & Reed disclosed 12.3% passive stake in 13G filing out last night after the close), CAM +0.8% ( approves $750 mln increase in share repurchase authorization ), FNSR +0.6% (prices $225 mln of 0.50% of Convertible Senior Notes due 2033; offering was increased by $25 mln), CBOE +0.5% ( declares special cash dividend of $0.50 per share; increases stock repurchase authorization by $100 mln), GM +0.5% (to halt Australia production by 2017), COG +0.5% (Barron's profiles positive view on Cabot Oil & Gas), YNDX +0.2% (announces proposed offering of $600 mln Convertible Senior Notes and a 3 mln share Increase in the Company's Open Market Share Repurchase Plan).
Analyst comments: GRPN +2.6% (upgraded to Outperform from Market Perform at Wells Fargo), EOPN +2.1% (initiated with a Buy at Janney ), XONE +1.8% (initiated with a Buy at Jefferies), RVBD +1.3% (initiated with a Buy at Citigroup), QCOM +1% (assumed with a Buy from a Neutral at Citigroup), VJET +1% (initiated with a Hold at Jefferies; tgt $40), FE +1% (FirstEnergy upgraded to Neutral from Sell at Goldman), FFIV +0.7% (initiated with a Buy at Citigroup ), ARCW +0.7% (initiated with a Buy at Brean Capital), DDD +0.5% and SSYS +0.4% (initiated with a Buy at Jefferies), MMM +0.4% (upgraded to Buy from Neutral at Nomura)